IRDA sets new norms: How much will LIC offload?

Published on Mon, Aug 25, 2008 at 14:25 |  Source : CNBC-TV18

Updated at Tue, Aug 26, 2008 at 17:28  

Like this story, share it with millions of investors on M3
0
0
Share on Tumblr

By Sajeet Manghat , CNBC-TV18:

Insurance Regulatory and Development Authority,  IRDA ,  has announced fresh investment guidelines that seek to create a level playing field between private players and LIC  (Life Insurance Corporation). The biggest impact of these guidelines will be on LIC. Earlier LIC was allowed to hold up to 30% of stake in any company but now it may be able to hold only up to 10%. It may have to dilute stake in companies where holding is more than 10%. LIC currently holds more than 10% in companies such as Ranbaxy , Mahindra  and L&T .

Company                      Stake (%)

 

 L&T                                16.78

 ITC                                 14.35

 M&M                               17.49

 Ranbaxy                         15.01

 ACC                               15.93

 

Will LIC bring down their stake?

 

In accordance to the new norms LIC will have to divest any stake above 10% that it holds. LIC may have to sell Rs 13,897 crore worth of stocks to comply with the new guidelines. It may also have to reduce its stake in LIC housing Finance and may sell about 30% stake in that company. However, if LIC is exempted from diluting its LIC housing stake, as it is the promoter, the fugures get reduced only by Rs 800 crore odd.

  

More on Moneycontrol

Trending News

Business News

Tech2's Nokia Lumia Contest is Live
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com